BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37916518)

  • 1. The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma.
    Asai Y; Yanagawa N; Osakabe M; Yamada N; Sugimoto R; Sato A; Ito K; Koike Y; Tanji T; Sakuraba M; Sato T; Sugai T
    J Surg Oncol; 2024 Feb; 129(2):381-391. PubMed ID: 37916518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
    Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
    Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung.
    Shikanai S; Yamada N; Yanagawa N; Sugai M; Osakabe M; Saito H; Maemondo M; Sugai T
    Ann Surg Oncol; 2023 Nov; 30(12):7527-7537. PubMed ID: 37280312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.
    Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP
    Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
    Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
    PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages.
    Barros MH; Hauck F; Dreyer JH; Kempkes B; Niedobitek G
    PLoS One; 2013; 8(11):e80908. PubMed ID: 24260507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer.
    Petrillo M; Zannoni GF; Martinelli E; Pedone Anchora L; Ferrandina G; Tropeano G; Fagotti A; Scambia G
    PLoS One; 2015; 10(9):e0136654. PubMed ID: 26335330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast.
    Jamiyan T; Kuroda H; Yamaguchi R; Abe A; Hayashi M
    Virchows Arch; 2020 Dec; 477(6):767-775. PubMed ID: 32607685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
    Mwafy SE; El-Guindy DM
    J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma.
    Lee WJ; Lee MH; Kim HT; Won CH; Lee MW; Choi JH; Chang SE
    Melanoma Res; 2019 Oct; 29(5):501-509. PubMed ID: 30575644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas.
    Lin MW; Yang CY; Kuo SW; Wu CT; Chang YL; Yang PC
    Ann Surg Oncol; 2016 Sep; 23(9):3071-81. PubMed ID: 27150441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of M2-macrophages in uveal melanoma and relation with survival.
    Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated CD163
    Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
    Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
    [No Abstract]   [Full Text] [Related]  

  • 17. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.
    Herwig MC; Bergstrom C; Wells JR; Höller T; Grossniklaus HE
    Exp Eye Res; 2013 Feb; 107():52-8. PubMed ID: 23206928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients.
    Antel K; Chetty D; Oosthuizen J; Mohamed Z; Van der Vyver L; Verburgh E
    Pathology; 2021 Aug; 53(5):628-634. PubMed ID: 33558066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
    Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
    Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma.
    Yanagawa N; Shikanai S; Sugai M; Koike Y; Asai Y; Tanji T; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    Thorac Cancer; 2023 Jul; 14(20):1911-1920. PubMed ID: 37208929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.